Karschnia P, Young JS, Wijnenga MMJ, Sciortino T, Teske N, Corell A, Wagner A, Youssef G, Park YW, Häni L, Jünger ST, Dono A, Ehret F, Mireles EEM, Neidert N, Bruno F, Tuchek CA, van der Vaart T, Rossi M, Nibali MC, Gay L, Gramelt A, Tandon N, Ahn SS, Chang JH et al. (2025)
A prognostic classification system for extent of resection in IDH-mutant grade 2 glioma: an international, multicentre, retrospective cohort study with external validation by the RANO resect group
Lancet Oncol, 26 (12), 1638-1650
DOI 10.1016/S1470-2045(25)00534-0, PubMed 41308678

Emblem KE, Ringstad G, Svensson SF, Vatnehol SAS, Storås TH, Vik-Mo EO, Heggebø LC, Brandal P, Eide PK (2025)
Intrathecal contrast-enhanced MRI reveals an alternative route for drug delivery and brain tumor visualization
Cancer Lett, 638, 218152 (in press)
DOI 10.1016/j.canlet.2025.218152, PubMed 41276108

Estabillo LL, Skaga E, Halldorsson S, Vik-Mo EO, Sandberg CJ (2025)
Drug resistant glioblastoma stem cells exhibit enriched stemness signatures and share extracellular matrix overexpression
BMC Cancer, 25 (1), 1655
DOI 10.1186/s12885-025-15163-z, PubMed 41146055